OKUR OnKure Therapeutics reports narrower Q4 2025 loss than estimates shares drop 204 percent in trading MDLN Medline sharp Q4 2025 EPS miss triggers investor selloff pushing shares down 318 today What independent research Investar ISTR Market Focus 20260427